Status: Recruiting
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Participants needed: 120
Trial details
Phase: Phase 2Age: 4-17Biological sex: AllType: InterventionalSponsor: Laboratoires TheaUpdated: Apr 22, 2026Locations: 11
Eligibility criteria
Informed consent signed and dated [+2]